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1. Introduction
The hexokinase-catalysed phosphorylation of glu-
cose by ATP occurs in all eukaryotic cells as the first
step in the utilization of glucose, and the reaction is
also widespread in prokaryotic cells; the subsequent
steps vary, as the glucose 6-phosphate formed in the
first step may have different metabolic fates in differ-
ent types of cell and in different physiological condi-
tions. Much information on hexokinases from differ-
ent species has accumulated since the pioneering
w xwork of Meyerhof 1 on yeast hexokinase, and there
are reviews on various aspects, including kinetics,
w xstructure, and genetics 2–9 .
Glucose is the preferred substrate of the hexoki-
nases, but they can also phosphorylate other hexoses
to varying degrees, as recognized by the recom-
mended name of hexokinase ATP:D-hexose 6-phos-
.photransferase, EC 2.7.1.1 . Only a few species, es-
pecially bacteria, are known to contain true glucoki-
nases ATP:D-glucose 6-phosphotransferase, EC
. w x2.7.1.2 , i.e., enzymes specific for glucose 7 .
Hexokinases from different species differ in
molecular mass and tissue distribution, and the en-
zyme often exists as a mixture of isoenzymes that
differ in kinetic characteristics and molecular mass.
In this review, we first give a broad picture of the
general characteristics of the hexokinases in different
phyla; we discuss whether a single kinetic model can
be used to rationalize the kinetic and regulatory
properties of the hexokinases; finally, we examine
similarities in primary structures and on the basis of
sequence alignments propose a phylogenetic tree and
model of molecular evolution to explain it.
2. General characteristics of glucose-phosphorylat-
ing enzymes
2.1. Isoenzymes
Multiple hexokinases were first demonstrated in
w xyeast 10 , which has three isoenzymes, hexokinases
 .  . w xP or A and P or B , and glucokinase 2,11–13 .I II
The existence of distinct isoenzymes was shown not
only in diploid strains, in which hexokinases P andI
P could have been dismissed as allelic variants, butII
w xalso in haploid strains 12,13 . In animals, hexokinase
w xisoenzymes were first reported in rodent liver 14–18 ,
but appear to be characteristic of all animals, includ-
w xing the human 19,20 . Isoenzymes have also been
w xfound in green plants 21 and in several, but not all,
w xinvertebrate species so far examined 7 . Vertebrate
tissues contain up to four isoenzymes, designated as
w xhexokinases A, B, C and D 18 on the basis of their
electrophoretic mobility; the alternative names hexok-
inases types I, II, III and IV, respectively, given by
w xKatzen et al. 22 , are in widespread use; hexokinase
 .D or IV is often called ‘glucokinase’, but, as we
shall discuss in Section 2.7, this name is unfortunate
because the four isoenzymes do not differ in their
specificity for glucose.
Comparisons between the isoenzymes from vari-
ous sources has led several groups to suggest that
evolution of the vertebrate hexokinases involved du-
plication and fusion of an ancestral hexokinase of 50
kDa that resembled the present-day yeast hexokinases
w xand mammalian hexokinase D in size 4,7,9,23–26 .
We shall discuss this question in Section 4.
2.2. Sugar specificity
It is widely believed that specificity has increased
during evolution, i.e., that the more specific enzymes
w xevolved from less specific ancestral proteins 27–29 ,
but one should not expect from this that the simpler
modern organisms will have less specific enzymes
than the more complex organisms, because all mod-
ern organisms have evolved to a high degree of
efficiency in occupying particular ecological niches.
As we will discuss in Section 3.4, at least three of the
four hexokinase isoenzymes in the rat have kinetic
properties that correlate well with the functions of the
organs in which they predominate, and there is no
reason to doubt that a similar degree of adaptation
exists in other organisms. Explanation for any differ-
ences in enzyme specificity between different types
of organisms should therefore be sought in differ-
ences in their present-day requirements and not in
any supposed closeness to their ancestors.
Examination of the glucose phosphorylating en-
 .zymes across the phyla Table 1 shows substantial
variation in hexose specificity, with the more specific
enzymes found generally in the simpler organisms;
animals lack enzymes with high specificity for phos-
phorylation of glucose, mannose or fructose at posi-
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Table 1
Specificity of hexokinases in different organisms
Taxon High specificity Intermediate specificity Low specificity
a w xArchaea Pyrococcus furiosus 30
b w x w x w xBacteria Streptococcus mutans 31 Leuconostoc meserentoides 32 Escherichia coli 33
w x w xE. coli 34 Streptomyces ˝iolaceruber 35
w x w xBacillus stearothermophilus 36 E. coli 37
w xZymomonas mobilis 38
w xAerobacter aerogenes 39
w xRhodospirillum rubrum 40
w xPseudomonas saccharophila 41
w xBre˝ibacterium fuscum 42
w x w x w xLower eukaryotes Euglena gracilis 43 Saccharomyces cere˝isiae 11,44 Sac. cere˝isiae 45
w x w x w xDictyostelium discoideum 46 Torulopsis holmii 47 Neurospora crassa 48
w x w x w xCandida sp. 49 Saprolegnia litoralis 40 Entamoeba histolytica 50
w x w xSap. litoralis 40 Trypanosoma equiperdum 51
w x w xGreen plants Peas 52 Wheat 53,54
w x w xAnimals Lobster 55 Vertebrates 4,56
aThe Archaea were formerly called Archaebacteria. The more recent name reflects recognition that these organisms constitute a domain
w xof life distinct from the bacteria 57 .
b w xThe Bacteria were known as Eubacteria during the period when the Archaea were regarded as members of the same kingdom 57 .
w xtion 6, whereas bacteria, apart from E. coli 33 , have
no unspecific hexokinases, and all of those that have
been described are either highly specific or at least
more specific than the enzymes of higher animals.
Prokaryotes and lower eukaryotes typically contain
a series of specific hexokinases that each act on one
hexose only, normally glucose, mannose or fructose;
in Pse. saccharophila, for example, glucokinase,
fructokinase and mannokinase exist as separate en-
w xzymes 41 , and various other organisms have spe-
w xcific glucokinases, such as E. coli 34 , Z. mobilis
w x w x38,58 , B. stearothermophilus 36,59,60 , Myxococ-
w x w xcus coralloides 61 , S. mutans 31 , A. aerogenes
w x w x w x39 , Bre. fuscum 42 , D. discoideum 46 . Some of
these highly specific glucokinases, such as those of
w x w xS. mutans 31 , A. aerogenes 39 and D. discoideum
w x46 , are not even inhibited by fructose or mannose, a
further contrast with vertebrate ‘glucokinase’, as dis-
w xcussed in Refs. 62,63 . A few bacterial enzymes are
somewhat less specific, such as the mannofructoki-
w xnase of L. meserentoides 32 and the mannoglucoki-
w xnase of Str. ˝iolaceoruber 35 .
The recently described glucokinase from the hy-
w xperthermophilic archaeon P. furiosus 30 is unusual
and intriguing. Like the bacterial glucokinases, it is
highly specific for glucose, inactive with fructose,
mannose or galactose, and only weakly active with
2-deoxyglucose; however, unlike them and all other
known hexokinases it uses ADP as phosphate donor
 .and hence has AMP as a product and has no
detectable activity with ATP or other potential donors
such as GDP or pyrophosphate. The authors suggest
that the specificity for ADP is related to the ability of
the organism to activate sugars after a period of
starvation, i.e., in conditions of very low energy
charge. By contrast, the thermoacidophile Sulfolobus
solfataricus appears to use ATP, but the enzyme
responsible was studied only in cell homogenates,
and although these homogenates could also phospho-
rylate fructose there was no information about whether
w xthe same enzyme was involved 64 .
 .A specific glucokinase EC 2.7.1.2 and a fructoki-
 .nase EC 2.7.1.4 appear to exist also in Eug. gracilis
strain Z grown either under autotrophic or hetero-
w xtrophic conditions 43 . Unfortunately, the author of
this work did not mention whether other sugars, such
as mannose, were tested, mannofructokinase and
mannoglucokinase being not uncommon. The glucok-
inase has a low affinity for glucose, with a reported
K of 8 mM, reminiscent of the half-saturation con-m
centration value for the vertebrate ‘glucokinase’, and
also of the value attributed to the N-acetylglucosa-
mine kinases that have often been misidentified as
w xglucokinase 65–67 . Nevertheless, it appears certain
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that Eug. gracilis has no unspecific hexokinases with
similar characteristics to those of plants and animals.
The yeast Sac. cere˝isiae contains unspecific hex-
okinases, two isoenzymes hexokinase P and P , thatI II
can phosphorylate keto- and aldohexoses fructose,
. w xglucose and mannose 2,45 , and a third isoenzyme,
glucokinase, that is much more specific for aldohex-
w xoses 11,13,44 ; it appears not to phosphorylate fruc-
w xtose in vivo 11 , and although it can phosphorylate
fructose in vitro, it does so with a high K evenm
though the K for glucose, about 0.03 mM, is them
.lowest of the three isoenzymes and a limiting rate
only 0.4% of that for glucose, making it far more
 .specific for glucose in comparison with fructose
than the other two isoenzymes. This makes yeast a
very different case from that of the rat discussed in
Section 2.7.
Unspecific kinases able to act on a wide variety of
hexoses are broadly distributed, not only in verte-
brates, but also in plant tissues such as wheat germ
w x w x53,54 , pea seeds 52,68 and the endosperm of
 . w xcastor oil beans Ricinus communis 69 , and are the
rule in insects and echinoderms for references, see
w x.Ref. 7 . Although specific kinases have been de-
w xscribed in Schistosoma mansoni 70 and Echinococ-
w xcus granulosus 71 , confirmation of the reported
substrate specificity would be welcome.
Vertebrate hexokinases typically act on mannose,
fructose and 2-deoxyglucose as well as glucose, the
preferred substrate; hexokinase D, the so-called ‘glu-
cokinase’, is no exception. In the rat, the most thor-
oughly studied organism, the four isoenzymes have
essentially the same relative specificity for glucose
w xand fructose 72 , despite frequent suggestions to the
contrary, as we shall discuss in Section 2.7.
In summary, the highly specific hexokinases are
found in bacteria and unicellular eukaryotes, while
the non-specific hexokinases are characteristic of
higher eukaryotes. The non-specific hexokinase in E.
w xcoli 33 does not fit this pattern, and its subunit
molecular mass of 25 kDa is also unusual for a
bacterial hexokinase, as we shall discuss in Section
2.6.
It would be useful to know whether the specific
bacterial hexokinases are homologous with the verte-
brate enzymes. High specificity is not itself unusual,
but substrate analogues are usually inhibitors, whereas
this is not the case for some of the bacterial glucoki-
w xnases 31,39 ; one may ask whether this implies
major structural differences between the active sites
of vertebrate and bacterial hexokinases. Z. mobilis
glucokinase is a special case, as it requires inorganic
w xphosphate for activity 73 , suggesting that the active
site for glucose, the first substrate, only becomes
available after phosphate binding. No corresponding
activation exists with eukaryotic hexokinases, and
when inorganic phosphate has an effect it is one of
inhibition. For example, in rat hexokinase A phos-
phate has a double action, counteracting glucose 6-
phosphate inhibition at low concentrations, but be-
coming an inhibitor at higher concentrations; in hex-
w xokinase B it is always an inhibitor 26 .
What selective advantages can explain why bacte-
ria have adopted highly specific hexokinases in their
metabolism with no isoenzymes, whereas animals use
isoenzymes with broad specificity? This question has
no clear answer at present, but there are several
related points that may shed light on it in the future,
such as the specificity of sugar transporters and the
availability of different sugars in the prebiotic
medium. Microorganisms generally experience dras-
tic changes in the composition of the media, both
qualitative and quantitative changes from which ver-
.tebrate cells are generally protected , and, in addition,
sometimes occupy very restrictive ecological niches,
but the short life-time of a typical bacterial cell
implies several generations with little change in the
range of sugars available. These two considerations
will produce a higher selective pressure for speci-
ficity than that experienced by vertebrate cells.
2.3. Specificity of the putati˝e ancestral hexokinase
One can imagine the ancestral prebiotic ‘cells’
functioning with limited enzyme resources, i.e., with
a small number of different enzymes with a very
broad specificity allowing them to react with a wide
range of related substrates; at the same time, they
must certainly have been much less efficient as cata-
lysts than present-day enzymes. Subsequent evolution
would have decreased the degree of substrate ambi-
guity and improved catalytic efficiency, but because
of constraints in the transition state it is not easy to
evolve an enzyme with both high activity and broad
specificity. Consequently, the degree of substrate am-
biguity of all modern enzymes may well be much
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less than that of primitive enzymes, so vertebrate
hexokinases ought to be considerably more specific
than the enzymes present in the ancestral cells.
It is far from certain which sugars were available
in prebiotic conditions, but some predictions can be
made on the basis of the present knowledge of chem-
ical synthesis and stability of compounds. The abun-
dance of carbohydrate in the world today and its
availability as a foodstuff for animals and microor-
ganisms results from the activities of plants, and does
not reflect the situation at the origin of life, whether
one assumes a prebiotic soup or any other type of
model. In recent years alternatives to the classical
w xmodel of the origin of life have been proposed 74 .
However, these should not alter the validity of the
.argument we now develop.
It is generally accepted that the primaeval soup
w xwas relatively rich in amino acids 75 , carbohydrates
w xbeing much less common 76,77 . Organic com-
pounds different from sugars may have been used
preferentially in fermentation by early bionts. The
prebiotic synthesis of sugars could have occurred
through the formose reaction or Butlerow reaction
 .polymerization of formaldehyde to sugars , which
yields numerous sugars with no selectivity, producing
almost all possible pentoses and hexoses, including
w xbranched chain sugars 78,79 . Under prebiotic condi-
w xtions, this reaction is not particularly efficient 80,81 ,
and in view of the instability of sugars in aqueous
w xsolutions at high temperatures 77 their concentra-
tions in prebiotic conditions must have been ex-
tremely low. Even aldohexoses like glucose and man-
nose, which appear to be more stable than aldopen-
w xtoses such as ribose 77 , are still quite unstable,
especially as the primitive ocean cannot have been
exactly neutral. The instability of the pentoses and
hexoses together with the low efficiency of the for-
mose reaction for production of sugars suggests that
w xglycolysis must have appeared relatively late 82 , as
the sugars would not have initially been available in
.large enough quantities.
In these conditions, selective pressure is likely to
have favoured enzymes with a relatively high affinity
for sugars, but low specificity. Afterwards, the sugar
composition would have progressively changed as a
consequence of metabolic activity, inducing new se-
lective pressures. This suggests that the high hexose
specificity of some of the present bacterial enzymes
does not reflect the properties of the early ancestral
enzymes, which were probably not only less specific
than the present bacterial enzymes, but also less
specific than the present vertebrate enzymes. It would
be interesting to know how much the hexokinases of
present-day anaerobes differ from those of aerobic
bacteria.
2.4. Hexokinases and transporters
Glucose entry into most cells is mediated by facili-
tated diffusion, the transporter being an integral
 w x .membrane protein see Ref. 83 for a review . Cer-
tain hexokinases have been suggested to be involved
in some way in the transport of glucose into the cell
 w x.for references, see Ref. 9 . This function would
presumably involve association with the plasma
membrane, though we do not know of any direct
evidence for this. It is true that an unidentified hexok-
 .inase in rat hepatoma but not in hepatocytes has
been reported to associate with the plasma membrane
w x84 , but in our view this has not been sufficiently
studied to allow definite conclusions to be drawn. In
mammalian cells several different proteins are in-
volved with the transport of glucose and fructose. In
the case of glucose there are at least five such
w xproteins 83,85 , Glut1, Glut2, Glut3, Glut4 and Glut7
Glut5 being a fructose transporter and Glut6 being
.non-functional which share with the hexokinases the
characteristics of differing in tissue distribution and
glucose affinity. Glut2 has the lowest affinity for
 .glucose K about 15 mM and Glut1, Glut3 andm
Glut4 have higher affinity, with K about 2–5 mM.m
They can transport also other sugars as fructose
 . Glut2 , 2-deoxyglucose Glut1, Glut2, Glut3 and
.  .Glut4 and galactose Glut1 and Glut3 . In general,
expression of the different transporters correlates with
expression of particular hexokinase isoenzymes: Glut1
correlates with hexokinase A, Glut2 with hexokinase
D, and Glut4 with hexokinase B, but at present there
is no evidence that this is due to common mecha-
nisms of genetic regulation.
The case of Glut2 is especially striking: although it
is also expressed in other cells, it is highly expressed
in hepatocytes and b-cells of pancreas, the two types
of cells where the presence of hexokinase D has been
w xestablished beyond doubt 62 . Moreover, it has a
half-saturation concentration for glucose similar to
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Table 2
The molecular dimensions of hexokinases
 .Taxon Organism Isoenzyme Molecular mass kDa
Native Subunit
w xArchaea P. furiosus 30 Glucokinase 93 47
w xBacteria B. stearothermophilus 36 Glucokinase 67 34.5
w xS. mutans 31 Glucokinase 41 24
w xE. coli 33 ‘Glucokinase’ 49 24.5
w xFungi Sac. cere˝isiae P , P 87 102 51I II
w xSac. cere˝isiae ‘Glucokinase’ 88 aggregates 51
w xProtozoa Try. brucei 89 Hexokinase 295 50.3
w xPlants Wheat germ L , L 53,54,90 50 50I II
w xWheat germ H , H 53 100I II
w xNematodes Hymenolepsis diminuta 91 Hexokinase 98
w xAscaris suum 92 Hexokinase 100 100
w xInsects Drosophila 93 Hexokinase A 47 47
w xEchinoderms Starfish 94 Hexokinase 50 50
w xChordates Lamprey 95 Hexokinase 90 90
w xRat Hexokinase A 96 98 98
w xRat Hexokinase B 23 96 96
w xRat Hexokinase C 97,98 99.5 98
w xRat Hexokinase D 99 49 49
that of hexokinase D; both have low affinity for
glucose compared with other transporters and other
hexokinases. This raises the question of whether the
hexokinase isoenzymes and the glucose transporters
may be homologous, with associations between par-
ticular isoenzymes and particular transporters to form
functional units, with close physical interaction, that
have co-evolved. Evidence will be needed, however,
to give credence to this idea, despite some attempts to
find interactions between transporters and hexokinase
isoenzymes.
w xFor example, Lachaal and Jung 86 studied the
interaction between human Glut1 and glucokinase
from B. stearothermophilus in an in vitro system
with the transporter incorporated into lipid vesicles.
Although they observed binding, the affinity was
rather low, with a dissociation constant of 5 mM at
least an order of magnitude greater than the concen-
tration of the enzyme in the cell. In addition, the
maximum effect occurred in unphysiological condi-
tions pH 4 and rather high concentrations of ADP
.and glucose 6-phosphate , and so the result must be
treated with caution. In any case, the great differ-
ences in structure between bacterial and mammalian
hexokinases, with no evident sequence similarity see
.Section 4.2 , makes it difficult to regard it as having
functional implications for mammals. Glucokinase
from B. stearothermophilus is much smaller in size
 .than mammalian ‘glucokinase’ hexokinase D , as
shown in Table 2, and has very different kinetic
properties, especially in relation to specificity of sug-
 .ars and nucleotides see Section 2.5 .
w xLachaal and Jung 86 suggested that bacterial
glucokinases and rat hexokinase D may share the
same structural organization, but this seems most
implausible on the basis of the kinetic properties and
the sequence comparisons shown in Figs. 3 and 5
 .below . They were probably influenced by the
nomenclatural confusion, which implies a specificity
for the rat enzyme that it does not possess, and by the
reported 22% sequence identity between Z. mobilis
glucokinase which is similar in size to the B.
.stearothermophilus glucokinase and rat hexokinase
w x w xD 100 . However, the paper 100 did not make it
clear how the value of 22% was obtained. The pro-
gram Align 1 shows only 14% identity, whereas
FastA 2 gives a somewhat different alignment with
1 A c c e s s e d t h r o u g h t h e I n t e r n e t a t
http:rrmolbiol.soton.ac.ukrcomputeralign.html.
2 A c c e s s e d t h r o u g h t h e I n t e r n e t a t
http:rrgenome.eerie.frrfastaralign-query.html.
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17% identity. In both cases, these percentages refer
 .as is usual to the longer sequence, which has 464
residues. However, if we recalculate them as percent-
ages of 327, the length of the Z. mobilis sequence,
they become 20% and 24%, respectively, in better
w xagreement with the value of 22% given in Ref. 100 .
This suggests that a more conventional way of ex-
pressing the degree of identity found would be 15.5%,
indicating no particular relationship.
2.5. Nucleotide triphosphate specificity
Although eukaryotic hexokinases prefer ATP as
the nucleotide substrate, bacterial enzymes appear
less specific and ITP is a relatively good substrate.
For example, glucokinase from B. stearother-
mophilus, which does not phosphorylate mannose,
galactose, fructose, 2-deoxyglucose, glucosamine or
xylose at concentrations of 1.0 mM the apparent Km
.for glucose being 0.52 mM , has K values of 0.06m
mM for ATP and 0.6 mM for ITP with similar Vmax
w xvalues 36 . By contrast, rat hexokinase D, despite its
much broader sugar specificity, has K 24-foldm
higher and V 8-fold lower for MgITP than formax
w xMgATP 101 . With the other isoenzymes MgITP
w xappears to be also a poor substrate 102 .
The specificity of the glucokinase from P. furiosus
w x for ADP 30 has been mentioned already Section
.2.2 . Another unusual example is provided by the
glucokinase from Propionibacterium shermanii, an
anaerobic bacterium; this enzyme, which has a
molecular mass of 30 kDa, can use ATP as phosphate
donor, but is much more specific for polyphosphate
w x103 .
2.6. Molecular mass
As illustrated in Table 2, most native hexokinases
from different sources show molecular masses of 50
or 100 kDa, with subunits, when they exist, also with
molecular masses of 50 or 100 kDa. The archaeal
w xhexokinases also fall into this pattern 30,64 , but
smaller values have been found for several eubacte-
w xria; for example, the enzymes of S. mutans 31 and
w xE. coli 33 , have subunit molecular masses of 24
kDa. A different glucokinase with a 34.5-kDa subunit
w xalso exists in E. coli 34 ; others of about 33 kDa
w xhave been purified from Z. mobilis 58 and B.
w xstearothermophilus 36 , in both cases isolated as
dimers; there are numerous other bacterial sugar ki-
nases with molecular masses in the range of 32–37
kDa, including fructokinases of Rhizobacterium legu-
w x w xminosarum 104 and Vibrio alginolyticus 105 , fruc-
w xtomannokinase of Fusobacterium mortiferum 106 ,
w xand ribokinase of E. coli 107 .
Apart from the hexokinase of the parasitic round-
worm A. suum, with a reported subunit molecular
w xmass of 100 kDa 92 , fungal and invertebrate hexok-
inases have a monomer molecular mass of 50 kDa
w x7 , although in a few cases they dimerize readily, as
in yeast. Vertebrate hexokinases are monomers of
100 kDa, with the exception of hexokinase D, a
monomer of about 50 kDa that does not dimerize
w x99,108 . Thus, apart from the 35-kDa bacterial en-
zymes the molecular masses fall in the geometric
w xseries 25:50:100. For more details see Ref. 7 .
It was tempting to speculate from the molecular
masses that the hexokinases of present-day organisms
might have derived from an ancestral gene specifying
a protein of about 25 kDa that is still present in some
w xbacteria 7 . The initial proposal was that the ances-
tral gene duplicated and fused to give a new gene for
a hexokinase of about 50 kDa, this gene being still
present in fungi and invertebrates, but that a further
duplication and fusion at about the time of the origin
of the invertebrates produced a gene for a protein of
about 100 kDa. For the 100-kDa hexokinases there is
good evidence for gene duplication and fusion, as we
shall discuss, but this hypothesis fails to account for
the 50-kDa hexokinase D of vertebrates. This isoen-
zyme may be a relic of an invertebrate gene that
escaped the duplication–fusion event at the origin of
vertebrates, and a similar enzyme may still therefore
be present in invertebrates; alternatively, the hexoki-
nase D gene could have appeared afterwards as the
consequence of the even fission of a gene coding for
a 100-kDa enzyme. Against the first hypothesis, no
enzyme similar to the vertebrate hexokinase D has
ever been found in invertebrate organisms, but we are
not aware of any systematic search for such an
enzyme.
The possibility of gene duplication and fusion
raises the question of whether the change from 50
kDa to 100 kDa corresponded to the acquisition of
new functions. For a long time, and until relatively
recently, it was believed that this change corre-
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sponded to the appearance of an allosteric site re-
sponsible for the strong inhibition by glucose 6-phos-
phate observed with 100-kDa vertebrate hexokinases,
but not with hexokinase D or yeast hexokinases, all
of them of 50 kDa. However, this attractive hypothe-
sis has now been disproved, as we shall discuss in
Section 3.1.
( )2.7. Hexokinase D or glucokinase?
 .Vertebrate hexokinase D or hexokinase type IV
has the typical specificity of a vertebrate hexokinase:
it is not specific for glucose, but catalyses the phos-
phorylation of fructose, mannose and 2-deoxyglucose
w xas well 62,63,72,102,109–113 . The practice of call-
ing it ‘glucokinase’ is very misleading, because it
suggests a correspondence with the true glucokinases
of bacteria, or at least with the somewhat specific
glucokinase from yeast. The only common point
between yeast glucokinase and vertebrate hexokinase
D is the molecular mass and not even this similarity
.applies to the true glucokinases of bacteria . Both the
sugar specificity and the kinetic characteristics are
quite different: vertebrate hexokinase D has a much
higher half-saturation concentration for glucose than
any of the yeast enzymes and is cooperative with
w xrespect to glucose 114,115 , a property not shown by
any of the yeast isoenzymes.
The name has more than just semantic importance,
w xdespite suggestions to the contrary 116 , because
there is abundant evidence that researchers who are
not specialists in vertebrate hexokinases have been
misled into thinking that vertebrate hexokinase D
corresponds to the real glucokinase in bacteria and
have created errors and confusion in discussions of
 w x.hexokinase evolution e.g., 21,117,118 . Griffin et
w xal. 117 , for example, express surprise that, ‘‘the rat
glucokinase was most closely related to the C-termi-
nal halves of the rat hexokinases whereas the yeast
glucokinase was most closely related to the yeast
hexokinases . . . This observation suggests that the
duplication leading to rat glucokinase was a separate
 .and more recent event from the duplication leading
to the yeast glucokinase, implying that the glucoki-
nase activities arose twice in evolution.’’ Such a
statement makes sense only on the assumption that its
authors think that hexokinase D is a true glucokinase.
w xSimilar statements made in Ref. 118 have clearly
w xmisled other authors, such as Kengen et al. 30 and
w xHsieh et al. 119 , who quote them in contexts show-
ing that they took the name ‘glucokinase’ to have
implications of specificity. Other examples may be
found in the older literature: for example, Ishikawa et
w xal. 60 included the rat-liver enzyme among hexoki-
nases that are ‘very specific for glucose’.
w xJang et al. 21 have recently studied two isoen-
zymes from the green plant thale cress Arabidopsis
)thaliana , and report that their sequences are, ‘‘simi-
lar to those of the mammalian glucokinase and yeast
hexokinase proteins but distinct from those of the
mammalian hexokinase proteins’’. Given that all of
the mammalian hexokinase proteins are similar, it is
clearly impossible for this conclusion to be correct
 .see Section 4.2, and Fig. 6 in particular ; such a
statement could only have been made by authors
under the impression that mammalian ‘glucokinase’
is not a hexokinase. Errors such as this arise directly
from the nomenclatural confusion.
Hexokinase D differs from the other vertebrate
hexokinases in having different promoters in liver
and pancreas, the tissue-specific alternative promoters
allowing tissue-specific regulation of the gene. No
corresponding regulation has been described for the
hexokinases of low K . Hexokinase D is encoded inm
 .the rat and in the human by a single-copy gene that
 w x.has 11 exons reviewed in Refs. 120,121 . The
transcripts present in the liver and b-cells share
sequences encoded by the last nine exons. The se-
quences of the liver and b-cell mRNA differ at their
5X-ends because the gene has two promoters, one of
which functions in b-cells and the other in the liver.
As translation is initiated within the tissue-specific
first exon, the sequences of amino acids 1–15 of the
liver and b-cell isoforms are different.
Hexokinase D activity was not found in the livers
w xof 13 species from six orders of birds 122 , nor in 13
species of higher reptiles of the order Squamata
w x123 . However, no studies were performed in pan-
creas and, as the expression of the hexokinase D gene
w xis tissue-specific 124 , the gene could be silent in
liver but expressed in pancreas. This is a relevant
problem because in the rat and human and presum-
.ably in all mammals the enzyme appears to play an
important role in insulin secretion, acting as a glucose
w xsensor 125 . Alternatively, the gene may be also
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inactive in the pancreas of Aves and Squamata, glu-
cose-sensing being achieved by a different mecha-
nism resulting in the known differences between
blood sugar levels in birds as compared to mammals;
the fact that total pancreatectomy in birds, lizards and
snakes is followed by a prolonged period of hypogly-
w xcaemia 126 is also pertinent. The same questions
apply to the absence of hexokinase C from the livers
of birds and higher reptiles. In this case, however,
almost nothing is known about the role of this isoen-
zyme in the utilization of glucose in any species.
What has become of the silenced gene? Is it now a
pseudogene or is it merely permanently repressed?
These questions could easily be answered with the
techniques now available, and the same ones apply to
the several mammalian species ruminants, felids and
. w xbats that lack hexokinase D 127 . Considerable
clarification of the roles of the different hexokinase
isoenzymes can be expected if the appropriate experi-
ments are carried out.
3. Functional organization of the hexokinases
3.1. Inhibition by glucose 6-phosphate
Strong inhibition by glucose 6-phosphate is often
said to be a striking property of the 100-kDa verte-
brate hexokinases that is not shared by the 50-kDa
enzymes, whether hexokinase D or the yeast hexoki-
nases. This idea, together with the evidence that the
catalytic activity was entirely in one half of the
100-kDa molecule, suggested that the active site pre-
sumably present in the other half at the time of the
original gene duplication had evolved to become a
regulatory site: this would bind glucose 6-phosphate
and account for the strong inhibition, and the absence
of the second half would explain why similar inhibi-
tion is not reported for the 50-kDa hexokinases.
Consistent with this idea, only one catalytic site
appears to exist in hexokinase A, located in the
C-terminal half. Mutations of residues in the N-termi-
nal half that correspond to catalytic residues in the
C-terminal half do not affect the catalytic activity of
the enzyme, and studies of molecular fragments pro-
duced by proteolysis or genetic manipulation are
 w x.likewise consistent references in Ref. 9 . As the
50-kDa isoenzyme hexokinase D is not inhibited by
glucose 6-phosphate at physiological concentrations,
but only by fructose 6-phosphate via a complex with
w xa separate regulatory protein 128 , it was tempting to
speculate that this regulatory protein could have
evolved similarly, with an allosteric site for fructose
6-phosphate rather than for glucose 6-phosphate; the
duplication that produced the 100-kDa hexokinases
after subsequent fusion could have occurred without
fusion to produce two separate molecules, hexokinase
D corresponding to the C-terminal catalytic half of
hexokinases A, B and C, and the regulatory protein
for hexokinase D corresponding to the N-terminal
regulatory half. This hypothesis has been very attrac-
tive, but it can now be ruled out completely, for
several reasons, as discussed more fully elsewhere
w x62,129 . The most serious objection to it is that
w xsequence data for the regulatory protein 62,128,130
do not support it at all, as its sequence appears to be
unrelated to that of any known protein.
Until fairly recently, therefore the strong inhibition
of hexokinase A by glucose 6-phosphate was thought
to be due to interaction with an allosteric site in the
N-terminal half of the molecule, whereas the C-termi-
nal half was responsible for all the catalytic activity.
It is perhaps worth remarking that the allosteric
hypothesis for the low-K hexokinases has a longm
w xhistory, being proposed by Crane and Sols 131 well
.before the term allosteric itself was introduced .
Nevertheless, doubts were raised by the fact that
some invertebrate 50-kDa hexokinases, such as
w xstarfish hexokinase 94,95 , seem to be inhibited by
glucose 6-phosphate.
It now seems clear from work of different groups
using different approaches that the C-terminal half of
hexokinase A provides both activities, not only catal-
ysis but also high sensitivity to inhibition by glucose
w x6-phosphate. For example, White and Wilson 25
reported that the C-terminal fragment of 51 kDa
obtained by digestion with trypsin retained full cat-
alytic activity, had separate sites for hexoses and
hexose 6-phosphates, and was very sensitive to inhi-
bition by glucose 6-phosphate. They accordingly sug-
gested a new view of the evolutionary relationship
between the hexokinases whereby the sensitivity to
glucose 6-phosphate arose before gene duplication
and fusion. According to this view, the ancestral
50-kDa ancestor of the 100-kDa mammalian hexoki-
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nases resembled the present-day starfish hexokinase
w x94,95 more closely than the yeast enzyme.
w xThe results of the report by White and Wilson 25
have been confirmed by other groups. Magnani et al.
w x132 have reported the functional expression of the
cDNA for C-terminal human hexokinase A in E.
coli, and showed the recombinant half-hexokinase
with only one glucose-binding site and only one
putative ATP-binding site to be catalytically active
and sensitive to inhibition by glucose 6-phosphate,
exactly like the complete enzyme. They again con-
cluded that the C-terminal half of human hexokinase
A contains both the catalytic site and the regulatory
site, and they argued that the evolutionary relation-
ships between the hexokinases should be modified to
allow for the appearance of a regulatory site before
the gene duplication.
w xArora et al. 133 have evaluated the role of the
N-terminal half of tumour hexokinase A by two
different approaches: first, they used site-directed
mutagenesis to assess the requirements of conserved
amino acid residues predicted to interact with glu-
cose; second, they characterized the overexpressed N-
and C-terminal halves of the enzyme. Replacing Ser-
155, Asp-209 and Glu-260, residues in the N-termi-
nal half predicted to interact with glucose, with ala-
nine residues did not affect either the catalytic activ-
ity or the inhibition by glucose 6-phosphate. The
overexpressed C-terminal polypeptide is catalytically
active and shows the same inhibition pattern as the
complete 100-kDa parent enzyme for inhibition by
1,5-anhydroglucitol 6-phosphate, an analogue of glu-
cose 6-phosphate. Kinetic analysis revealed that this
analogue is linearly competitive with the substrate
ATP both in the intact enzyme and in the C-terminal
half, with K of 88 mM for the intact enzyme andi
118 mM for the C-terminal half. However, the N-
terminal half was also able to bind ATP and glucose
6-phosphate.
w xArora et al. 133 concluded that the N-terminal
part of hexokinase A might modulate the binding of
the enzyme to mitochondria. There is a highly con-
served dodecapeptide at the beginning of the N-
w xterminal sequence 117 responsible for the interac-
w xtion with a porin 134 . On the other hand, there is a
binding site for glucose 6-phosphate that controls the
binding of the brain enzyme to mitochondria, regulat-
ing the relative levels of soluble and membrane-bound
forms. It has long been known that the presence of
this effector causes hexokinase A to dissociate from
w xthe membrane 135–138 , an observation that has
been the basis of a simple and rapid purification of
w x w xhexokinase A from brain 139 . Arora et al. 133
proposed that the N-terminal half might serve as a
spacer between the membrane and the catalytic C-
terminal half of the enzyme, allowing this to interact
more easily with the next glycolytic enzyme, i.e.,
phosphoglucose isomerase.
An alternative to explain the inhibition by glucose
6-phosphate is to suppose that it is ordinary product
inhibition. If this were the case one would expect
some correlation between the inhibition constants
K Glc6P for glucose 6-phosphate and the correspond-i
ing half-saturation concentrations K Glc for glucose0.5
across the range of isoenzymes, and Table 3 accord-
ingly compares these. As the data come from work of
different groups under non-identical conditions the
orders of magnitude rather than the exact values
should be considered. However, for each enzyme we
have used K Glc and K Glc6P values from the same0.5 i
research groups. For some of the rat isoenzymes
more recent values of K Glc are available, but using0.5
these instead of those listed in Table 3 leaves the
Glc Glc6P ranking of K rK ratios right-hand column of0.5 i
.Table 3 essentially unchanged.
Analysis of these results shows that there is no
difference between 50- and 100-kDa species in rela-
tion to glucose 6-phosphate inhibition, and the differ-
ence between hexokinase D and the other three mam-
malian isoenzymes especially hexokinase A, which
.has essentially the same ratio is much less than one
would suppose from the common view that hexoki-
nase D is not subject to inhibition by glucose 6-phos-
phate. Of course, the inhibition of hexokinase D by
glucose 6-phosphate must be physiologically irrele-
vant, but that is not the point here: what is important
is that as K GlcrK Glc6P value for hexokinase D is0.5 i
similar to the others there is no reason to postulate
any special explanation for the strong inhibition of
the low-K isoenzymes. Rather one should see them
weak binding of glucose 6-phosphate to hexokinase
D as a natural consequence of the much weaker
binding of glucose to this isoenzyme than to the
others.
All of these considerations make it unreasonable to
exclude the possibility that all enzymes catalysing the
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Table 3
Inhibition of different hexokinases by glucose 6-phosphate
a b Glc c Glc6P c Glc Glc6P .  .  .Hexokinase Molecular mass kDa K mM K mM K rK0.5 i 0.5 i
w xRat hexokinase C 97 100 0.007 0.92 0.008
w xH. diminuta 91 50 0.09 5.2 0.02
w xRat hexokinase D 140 50 5 60 0.08
w xLobster hexokinase II 55 50 0.08 0.8 0.1
w xWheat hexokinase L 141 50 2.5 16.5 0.15II
w xRat hexokinase A 97 100 0.045 0.21 0.21
w xStarfish 95 50 0.045 0.07 0.64
w xA. suum 92 100 4.7 3.4 1.38
w xRat hexokinase B 97 100 0.23 0.16 1.44
w xSea urchin 95 50 0.35 0.06 5.8
aThe enzymes are ordered according to the ratios shown in the right-hand column.
b  .To facilitate comparison the molecular masses shown are approximate for more precise values see Table 2 .
cFor each hexokinase, both kinetic constants are from the same group; all were obtained from kinetic experiments apart from the K Glc6Pi
w xfor wheat hexokinase L 141 , which was obtained fluorimetrically.II
phosphorylation of hexoses follow essentially the
same mechanism, and that the range of types of
kinetic behaviour derive from quantitative differences
in rate constants.
w xBlasquez et al. 142 have reported that the yeast´
hexokinases, P and P , but not the third isoenzymeI II
 .glucokinase , are sensitive to inhibition by trehalose
6-phosphate. This could play a role in the regulation
of hexokinase activity, as the intracellular concentra-
tion of trehalose 6-phosphate has been estimated to
be in a range close to the observed inhibition con-
stant. From the point of view of evolution it will be
interesting to have information about the effect of
this ester phosphate in hexokinases of other species.
3.2. Two acti˝e sites on hexokinase B: kinetic conse-
quences
For many years it appeared that despite the dimer-
like structures of the 100-kDa mammalian hexoki-
nases each contained only a single active site capable
of catalysing the phosphorylation of glucose. This
w xstill seems to be true of hexokinases A and C 25,26 ,
and it would be surprising if it turns out not to be: in
the case of hexokinase A so much work has been
done that it is hard to believe that the existence of a
second catalytic site on the molecule could have
escaped all efforts to detect it until now; hexokinase
C has been less intensively studied, but the very rapid
accumulation of amino acid substitutions in its N-
terminal half, discussed in Section 4.1, argues against
the maintenance of a functional active site in this half
of the molecule.
Nonetheless, recent work by two different groups
w x143–145 has produced just such a surprise in the
case of hexokinase B, which does appear to have a
functional active site in the N-terminal half of the
molecule. Not only complete human hexokinase B,
but also its N- and C-terminal halves, have been
w xexpressed as separate molecules in E. coli 143 .
When extracted, each of the three molecules proved
to be catalytically active, with a specific activity for
the complete enzyme of 147 unitsrmg, not very
different from the sum of the separate values for the
N- and C-terminal halves 94 and 60 unitsrmg,
.respectively ; the K values for glucose were similarm
for the three cases, 0.34, 0.46 and 0.51 mM, respec-
tively, with somewhat greater differences between the
three K values for ATP, 1.02, 0.78 and 3.8 mM,m
w xrespectively. Ardehali et al. 143 concluded that the
activity of the whole enzyme might be a combination
of the activities of the two halves.
Although this interpretation appears reasonable,
some caution is appropriate because unless the Km
values are the same the kinetics of a mixture of
Michaelis–Menten activities should not follow
Michaelis–Menten kinetics exactly, as pointed out by
w xTsai and Wilson 144 in the context of their similar
results; why, therefore, were deviations from
Michaelis–Menten kinetics not detected for hexoki-
nase B in the past, even though the known non-
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Michaelis–Menten behaviour of hexokinases C and
w xD 63 had led various investigators to look for them?
Calculation of the appearance of the plots expected
from the parameters given shows that the expected
deviations from Michaelis–Menten kinetics with re-
spect to glucose are so small that they would be
virtually undetectable. Similar calculations with the
.same conclusion were done by Tsai and Wilson
w x144 with their own data. They studied complete
molecules of hexokinase B in which mutations in one
or other half eliminated one or other active site, and
they found less variation in the kinetic constants Km
values for glucose all about 0.14 mM, and values of
0.64, 1.09 and 0.45 mM for the K for ATP with them
wild-type, C-terminal active and N-terminal active
.molecules, respectively than was found with the
w xhalf-molecules 143 considered above.
The somewhat larger differences between the Km
values for ATP suggests that somewhat greater devia-
tions from Michaelis–Menten kinetics with respect to
ATP might have been observed for the complete
enzyme. However, they would still be small, and if
they had been observed they could have been at-
tributed to the difficulties of controlling the concen-
 2y.tration of the true substrate MgATP without af-
w xfecting other ions liable to affect the kinetics 62 .
w xMore recent studies by Tsai 146 , at present pub-
lished only in abstract, set out to reconcile the exis-
tence of two active sites on hexokinase B with the
observation that it can be inactivated by a single
w xmolecule of N-bromoacetylglucosamine 147 , imply-
ing that glucose binds with a 1:1 stoichiometry. He
proposes that although glucose can bind to either of
the two sites to give a catalytically active complex,
the conformational change that accompanies glucose
binding affects both sites and thus prevents binding
of more than one glucose molecule at a time. It
remains to be seen whether this type of model can
w xaccount for the flux-ratio data for hexokinase B 148 ,
w xwhich have generated some controversy 149–151
without leading to any fully convincing conclusion.
3.3. Inhibition of hexokinase C by excess glucose
The mammalian hexokinases A, B and D, the
characteristic isoenzymes of brain, muscle and liver,
respectively, have been studied much more thor-
oughly than hexokinase C, probably because this last
is absent from many tissues, or present only in low
quantities, and because its physiological role is less
clear. The distinctive feature of this isoenzyme, which
occurs in many other vertebrates as well as mammals
w x4 , is the substrate inhibition by excess glucose. This
may be related to the product inhibition of the other
two 100-kDa isoenzymes by glucose 6-phosphate,
and it is worthwhile to examine whether variants on a
common mechanism can account for both phenom-
ena.
Let us postulate that the ancestral hexokinases
followed a random-order mechanism in which either
glucose or MgATP could bind to the enzyme as a
first substrate; the binary complex produced could
then react with the other substrate to produce a
catalytically active ternary complex. In fact, the
mechanism followed by yeast hexokinase has a sub-
w xstantial random component 2 , and, although hexoki-
nase D appears to react very largely with glucose
binding as first substrate, there is evidence that the
binary complex of the enzyme with MgATP can also
w xlead to products 152 . This example suggests an
evolutionary trend towards a more ordered pathway
in which the less favoured binary complex either
disappears from the mechanism or becomes a dead-
end complex unable to continue along the catalytic
route. If hexokinase C differed from the other isoen-
zymes in having a preferred order with MgATP
before glucose, the same evolutionary hypothesis
would predict inhibition by glucose in a dead-end
reaction. Moreover, the inhibitory concentration of
glucose should vary with the MgATP concentration,
as indeed is observed: with hexokinase C of ascites
tumour the concentration of glucose needed for inhi-
bition increases as the MgATP concentration in-
w x  .creases 153 Fig. 1 . For example, at 0.2 mM
MgATP glucose concentrations above 0.1 mM inhibit
strongly, whereas at 10 mM MgATP the inhibition is
weaker, with a maximum rate at 0.2–0.5 mM glu-
cose. The behaviour of frog hexokinase C is similar
w x154 .
The corresponding phenomenon for the hexokinase
isoenzymes that prefer to bind glucose first would be
substrate inhibition by MgATP, but this has not been
reported. However, inhibition by glucose 6-phosphate
is competitive with respect to MgATP, not, as one
might naively expect, with glucose, suggesting that
glucose 6-phosphate can bind to the MgATP binding
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Fig. 1. The effect of ATP on the inhibition of hexokinase C by
excess glucose. The figure shows data for the dependence of the
rate of glucose phosphorylation catalysed by hexokinase C at
w xthree different concentrations of ATP 153 . Adapted from Ref.
w x153 .
site or, at least, to the same conformation to which
MgATP binds. When MgATP binds in this site it
does not prevent glucose from binding to produce a
catalytically active ternary complex, but when glu-
cose 6-phosphate binds to the MgATP site, glucose is
excluded and inhibition results. In the case of hexoki-
nase D, glucose is clearly the first substrate, with
only about 1% of the reaction occurring with MgATP
binding first. Thus, MgATP binds to the free enzyme
with much less affinity than glucose and glucose
6-phosphate does likewise, and no inhibition by ei-
ther MgATP or glucose 6-phosphate is evident at low
physiological concentrations.
The general hypothesis is therefore that if MgATP
can bind as first substrate then glucose 6-phosphate
can compete with it for the binding site of the
g-phosphate and prevent catalysis. An apparent diffi-
culty with this idea is that the isotope-exchange
w xstudies of Gregoriou et al. 148,152 provided no
evidence for the existence of dead-end complexes.
This difficulty is, however, apparent and not real,
because dead-end reactions are completely invisible
to the flux-ratio method used in these studies, i.e., the
fact that they were not observed provides no evidence
either for or against their existence.
Light could perhaps be shed on these ideas by
kinetic studies of the 25-kDa bacterial hexokinases,
such as those of S. mutans and E. coli, but unfortu-
nately this information is not at present available.
Some detailed kinetic studies of Z. mobilis glucoki-
w xnase 73 reveal some major differences in kinetic
behaviour from that observed with the mammalian
enzymes, as noted in Section 2.2; in addition, as
discussed in Section 4.2, there is little or no evidence
of structural similarity between the bacterial and eu-
karyotic enzymes. If this is maintained it suggests
that little could be learned about the mechanisms of
the eukaryotic enzymes by studying the kinetics of
those of bacteria.
3.4. Functional adaptation of the rat isoenzymes
Hexokinase A is the predominant isoenzyme in rat
brain, hexokinase B predominates in muscle, and
hexokinase D in hepatocytes and pancreatic islets.
The kinetic properties of these three isoenzymes are
well adapted to the presumed roles of glucose phos-
phorylation in the different locations, as may be seen
in Fig. 2. Both hexokinases A and B are virtually
saturated at glucose concentrations in the normal
physiological range for the blood, which is indicated
by the shaded region of the figure, and thus their
Fig. 2. The correlation of kinetic properties with physiological
roles. The figure compares the kinetic properties of the four
isoenzymes of hexokinase found in the rat. The physiological
range in the blood is indicated by the shaded region. The three
insets show the curves redrawn with a linear instead of a logarith-
mic scale of glucose concentration, and provide a qualitative
illustration of the different kinetics: hexokinases A and B follow
Michaelis–Menten kinetics; hexokinase C is inhibited by excess
glucose; the curve for hexokinase D is somewhat sigmoid, with a
Hill coefficient of 1.6, this sigmoidicity accounting for the greater
steepness of the curve for hexokinase D in the main part of the
figure.
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kinetic activity is largely unaffected by variations
within this range; because of this saturation devia-
tions from Michaelis–Menten behaviour would have
no significant effect, and in fact both isoenzymes
follow Michaelis–Menten kinetics. However, when
the availability of glucose is pathologically low, it is
more important to satisfy the glucose needs of the
brain than those of other tissues, and it is significant
that the low K of hexokinase A allows it to retainm
more than 70% of full activity at glucose concentra-
tions as low as 0.1 mM. If, as we have argued in
Section 3.1, the strength of product inhibition by
glucose 6-phosphate is largely determined by the
affinity for glucose, then the low K values form
glucose are well adapted to the need for hexokinases
A and B to be sensitive to accumulation of glucose
6-phosphate.
As seen also in Fig. 2, the kinetic behaviour of
hexokinase D is very different, but this also accords
well with the needs of the liver and pancreas to
respond to variations in the blood-glucose concentra-
tion. The small degree of sigmoidicity in hexokinase
w xD 114,115 , coupled with its relatively low affinity
for glucose, allows it to have a middle range of
activity almost exactly the same as the physiological
range of blood glucose concentrations. If a side-effect
of the low affinity for glucose is that hexokinase D is
virtually unaffected by glucose 6-phosphate at any
reasonable physiological concentration then this also
corresponds with the probable physiological needs.
This picture will probably need to be complicated
somewhat in the light of recent observations on the
translocation of hexokinase D between the nucleus
w xand the cytoplasm 155–157 , but it would be prema-
ture to attempt this now.
The kinetic behaviour of hexokinase C is much
harder to rationalize. However, isoenzymes inhibited
by excess glucose are widely distributed in different
w xspecies 56 , and so it is reasonable to assume that it
has some function, even if it is not very obvious at
present what it is. The effect of the negative slope in
the physiological range of glucose concentrations
must be to flatten somewhat the curve representing
the total activity of the 100-kDa hexokinases, in the
limit making their composite effect virtually indepen-
dent of the glucose concentration. However, in most
tissues the activity of hexokinase C appears too low
for any such effect to be significant.
4. Similarities in primary structure of hexokinases
4.1. Rat isoenzymes
Close structural relationships of hexokinase D with
the other vertebrate hexokinases have long been well
documented. For instance, the amino acid composi-
tions of the four isoenzymes were found to be strik-
ingly similar, especially those of hexokinases B and
w xD 4,158 , and the analysis of the peptide maps of
hexokinases B and D confirmed the resemblance, as a
significant number of common peptides were found
w x159 . More direct support for similarity between the
sequences of the N- and C-terminal halves came
later, from isolation and sequencing of several tryptic
peptides from hexokinase C and comparison of these
w xwith yeast hexokinase 160 .
When the sequences became known of hexoki-
w x w x w xnases A 161 , B 162 , and C 163 , as well as those
w xof hexokinase D from both rat liver 164 and human
w xpancreas 165 , the general similarity between all the
rat enzymes was confirmed though without any spe-
.cial similarity between hexokinases B and D , and the
hypothesis that the 100-kDa hexokinase could be the
result of gene duplication and fusion was reinforced.
The sequence similarities are illustrated in Fig. 3,
which represents the dot plots corresponding to the
four rat hexokinases. Several important points are
evident in this figure. First, the 100-kDa hexokinases
are all dimer-like, i.e., in each case the N- and
C-terminal halves of the molecule resemble one an-
other, as is clear from the strong secondary diagonals
in each comparison of a 100-kDa molecule with any
other. However, none of the enzymes shows any
convincing evidence of a 25-kDa unit, and if there
was ever a gene duplication and fusion of a 25-kDa
molecule sufficient mutations have since accumulated
to obliterate any evidence for it. The N-terminal half
of hexokinase C diverges more than the C-terminal
half from the other hexokinases, and hexokinase D,
with a molecular mass half those of the other three,
resembles the C-terminal half of a 100-kDa hexoki-
nase more than the N-terminal half. In general, the
N-terminal halves show more evidence of divergent
evolution than the C-terminal halves.
The same characteristic is evident in a tree Fig.
. 4a constructed from the aligned sequences treating
the N- and C-terminal halves of the 100-kDa hexoki-
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Fig. 3. Comparison of the amino acid sequences of the four rat isoenzymes of hexokinase. Each dot represents an identical residue in the
sequences compared, but a dot is only shown if such an identity is the centre of a region of nine residues containing at least four
identities. The squares along the main diagonal show comparisons of each sequence with itself, and the secondary diagonals in the
comparisons for hexokinases A, B and C show that each of the 100-kDa hexokinases is ‘dimer-like’, i.e., that its N-terminal half has a
high degree of similarity to its C-terminal half. The absence of further diagonals intermediate between those that can be seen indicates a
lack of evidence that the 50-kDa sequences are derived from duplication of a putative 25-kDa ancestral sequence.
.nases as separate sequences . Apart from an anomaly
with hexokinase C that we shall consider shortly,
there is a high degree of self-consistency, with a well
 .defined branch point point 1 in the tree at which
hexokinase D diverges from hexokinases A and B at
about the same time that the N- and C-terminal
halves of hexokinases A and B diverge from one
another. Both halves of hexokinases A and B suggest
that the divergence of these two isoenzymes from one
another started more recently.
Hexokinase C fits badly into this tree: the N-termi-
nal half suggests that it started to separate from the
 .other three isoenzymes at an early moment point 2 ,
but the C-terminal half indicates equally clearly that
this separation was a much more recent event point
.3 than the divergence of hexokinase D, possibly at
about the same time that hexokinases A and B started
to diverge from one another.
 .The tree can be rationalized Fig. 4b if hexokinase
D and the C-terminal halves of the 100-kDa isoen-
zymes have evolved at a consistent rate since the
original duplication and fusion produced the 100-kDa
ancestral molecule, but the N-terminal halves have
evolved faster, about 25% faster in the case of hexok-
inases A and B, and more than twice as fast in the
case of hexokinase C. This interpretation implies that
the separation of hexokinase D from the other verte-
brate hexokinases occurred around 700 Myr ago, i.e.,
that it is much more ancient than the radiation that
produced the different vertebrate classes about 350
.Myr ago . Comparisons of the hexokinase D se-
quences of Xenopus lae˝is and mammals made by
w xVeiga-da-Cunha et al. 168 indicate about 80% iden-
tity, consistent with this interpretation.
More rapid evolution of the N-terminal half of the
100-kDa isoenzymes accords well with the evidence
discussed in Section 3.1 that the catalytic site of
hexokinase A is in the C-terminal half. This was also
believed to be true of hexokinases B and C until the
recent studies that showed hexokinase B to have two
catalytic sites, one in the N-terminal half and the
w xother in the C-terminal half 143–145 . The rapid
evolution of the N-terminal half of hexokinase C is
quite consistent with the recent evidence that it has
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w xonly a single active site 26 . Its rapid evolution may
be related to its lack of a clear physiological role, as
its structure may have been less constrained during
evolution than the others.
4.2. Low molecular mass hexokinases
Fig. 5 illustrates dot plots comparing the sequences
of hexokinase D, the three yeast isoenzymes and the
E. coli glucokinase with subunit molecular mass of
34.5 kDa. There is significant similarity between all
of the 50-kDa enzymes: the most similar are yeast
isoenzymes P and P , but yeast glucokinase is muchI II
more similar to the other yeast isoenzymes than it is
to rat hexokinase D. Thus rat hexokinase D and yeast
glucokinase do not form a natural group; if anything
hexokinase D is more similar to yeast hexokinase PI
than it is to yeast glucokinase. This feature has
w xsurprised some authors 117,118 , who are misled by
the misnomer of ‘glucokinase’ for rat hexokinase D.
Despite the contention that the two hexokinases
from the plant A. thaliana are similar to rat hexoki-
nase D but distinct from the mammalian 100-kDa
w xhexokinases 21 , comparison with one another and
with two rat isoenzymes and yeast glucokinase Fig.
.6 shows that the data are entirely consistent with
what one would expect from the phylogenetic separa-
tion between green plants, mammals and yeast, and
from the fact that the two plant hexokinases are
 .similar in size 496 and 502 residues to yeast glu-
 .cokinase 499 residues : the two plant proteins re-
semble one another very closely, and resemble any
mammalian sequence about as much as they resemble
any yeast sequence, or as much as the yeast and
mammalian sequences resemble one another. There is
easily recognizable similarity between A. thaliana
hexokinase 1, for example, and either half of hexoki-
nase A; this similarity is particularly obvious between
residues 65 and 355 of the plant sequence. By con-
 .Fig. 4. The hexokinase C anomaly. a The tree shown was
obtained by the UPGMA unweighted pair-group method with
. w xarithmetic averages 166 from the sequences of the rat and
human isoenzymes of hexokinase aligned as given by Fothergill-
w xGilmore and Michels 167 , each half of each of the 100-kDa
sequences being treated as a separate protein. The scale of amino
acid substitutions measures distances from ancestors to descen-
dant, and the numbers must be doubled to obtain descendant-to-
descendant distances, e.g., the junction at 12 substitutions be-
tween the N-terminal halves of human and rat hexokinase A
indicates that these sequences differ at 24 loci. The numbered
branchpoints illustrate the anomaly with hexokinase C: although
 .there is a well defined point labelled 1 indicating that the two
hexokinase D sequences differ from any of nine of the other
half-sequences at about 140 loci, the sequence of the N-terminal
half of hexokinase C differs at more than 200 loci from any of
 .the other sequences point labelled 2 , whereas the C-terminal
half differs from the corresponding hexokinase A and B se-
 .quences at about 100 loci point labelled 3 . As these values
differ by much more than statistical scatter they suggest that
hexokinase C separated from hexokinases A and B both before
 .and after the separation of hexokinase D. The model shown in b
 .is an attempt to rationalize the results of a , by supposing that
after duplication produced the 100-kDa molecules the C-terminal
halves of these molecules, together with the 50-kDa hexokinase
D molecules, accumulated substitutions at the rate of about 0.055
 .per Myr indicated by lines of normal thickness , whereas the
N-terminal halves of hexokinases A and B evolved faster 0.070
.per Myr; thicker lines and that of hexokinase C much faster
 .0.125 per Myr; very thick lines . The scale of time is calibrated
by assuming that the rat and human lineages separated about 65
Myr B.P. The human hexokinase C descendant is shown in
w xparentheses because, although this enzyme is known to exist 20 ,
it has not been purified and no sequence data are available.
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trast, the C-terminal thirds of the plant enzymes show
almost no recognizable similarity with the rat or yeast
enzymes, and it is noticeable that this is also the
region where the yeast and rat sequences differ the
most from one another. Despite what is claimed in
w xRef. 21 , the 50-kDa hexokinases do not form a
natural group from which the 100-kDa hexokinases
are excluded.
E. coli glucokinase, with a subunit molecular mass
w xof 34.5 kDa 34 , shows no similarity to the other
 .hexokinases of low molecular mass Fig. 5 , and the
w x same is true of S. coelicolor glucokinase 169 not
.illustrated . This does not exclude the possibility of
homology with the 50-kDa hexokinases, but if any
exists the many mutations during the long period
since the separation of prokaryotes and eukaryotes
have eliminated any evidence for it. As we shall
discuss in Section 4.4, other bacterial hexokinases do
apparently have non-hexokinase homologues among
the enzymes of higher organisms.
A partial determination of the first 10 residues
from the N-terminal of the ADP-dependent glucoki-
nase from the archaeon P. furiosus indicated no
similarity with other hexokinases or with any other
w xsequences in the SwissProt database 30 . However,
Fig. 5. Comparison of 50-kDa hexokinase sequences. Dots are
drawn according to the same criteria as in Fig. 3. The bottom line
shows comparisons with the 34.5-kDa glucokinase from E. coli.
The absence of recognizable diagonals indicates that this enzyme
does not resemble any of the others.
Fig. 6. Comparison of mammalian, plant and yeast hexokinase
sequences. Dots are drawn according to the same criteria as in
Fig. 3. The isoenzymes labelled Plant 1 and 2 are hexokinases 1
w xand 2 from A. thaliana 21 .
this limited information does not allow any conclu-
sions to be drawn.
4.3. Phylogenetic relationships between hexokinases
Fig. 7 shows an attempt to accommodate all of the
sequence relationships into a single model for the
evolution of the hexokinases. Some points seem to be
uncontrovertible, despite suggestions otherwise in the
literature. In each of the kingdoms where isoenzymes
are found these isoenzymes have arisen indepen-
dently, even though the yeast isoenzymes are rela-
tively ancient, their relationships are with one another
and not with the isoenzymes in other kingdoms. In
particular, vertebrate hexokinase D has nothing apart
from its size and the unfortunate misnomer of ‘gluco-
kinase’ to connect it with yeast glucokinase, and still
less with any bacterial glucokinase. Although the
bacterial enzymes are tentatively included in Fig. 7,
there is in reality very little evidence to suggest that
they are related, beyond the fact that they catalyse the
same reactions, and some have a size suggestive of
relationship to the putative 25-kDa ancestor of the
eukaryotic hexokinases although as discussed in Sec-
tion 2.6, most of the known bacterial hexokinases are
.in the 32–37-kDa range . Moreover, this ancestor is
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Fig. 7. The phylogeny of hexokinases. The tree attempts to summarize all of the comparisons discussed in the text. In accordance with the
tree drawn in Fig. 4b, the duplication that produced the 100-kDa animal hexokinases is shown as occurring no earlier than the branchpoint
that separated the 50-kDa hexokinase D from the other isoenzymes. Because of the need to show different amounts of detail in different
parts of the tree there has been no attempt to draw it with a consistent scale of time. The line leading to the bacterial hexokinases is
discontinuous because there is no direct evidence that any of these is homologous with the eukaryotic enzymes.
itself purely hypothetical, as no suggestion of gene
duplication remains in the 50-kDa sequences that can
be examined today.
Before the amino acid sequences became known
the suggestion of a special similarity between hexoki-
nases B and D seemed to be most easily accommo-
dated by a model in which the 50-kDa hexokinase D
is descended from a fragment produced by fission of
w xa 100-kDa ancestor 4 . This possibility is not dis-
proved by any data now available, but the original
reason for proposing it no longer applies, and no
trace of the other 50-kDa fragment presumably pro-
duced by the fission has been found. It seems more
parsimonious, therefore, to suppose that hexokinase
D separated from the 100-kDa isoenzymes before the
duplication and fusion that produced them, and Fig. 7
is drawn in accordance with this interpretation. Anal-
ysis of the gene organization of hexokinase B
w x170,171 showed the same arrangement of introns in
the two halves of the gene and in the hexokinase D
gene. However, corresponding data are not available
for other hexokinase genes, and consequently this
information provides no basis for preferring any par-
ticular model of hexokinase evolution. If the model
of Fig. 7 is correct, we should certainly expect the
genes for hexokinases A and C to have the same
intron organization as that reported for hexokinase B,
w xas Printz et al. 145,171 have suggested, and it
would not be surprising if more distantly related
genes shared it as well.
4.4. Structural similarities with other proteins
Although, as discussed in Section 4.2, there is no
convincing evidence of homology between bacterial
glucokinases and the hexokinases of higher organ-
isms, the fructokinases of several bacteria appear to
be related to a human enzyme, adenosine kinase, with
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w xtwo markedly similar regions in the sequences 172 ;
for example, residues 294–305 of the human enzyme
are identical at 11 out of 12 sites to residues 243–256
w xof fructokinase from V. alginolyticus 105 . Neither
of the two consensus sequences identified in Ref.
w x172 occurs in any of the hexokinase sequences
represented in Figs. 3, 5 and 6, however, and so it is
not possible to relate this discovery to the phyloge-
nies that we have been considering.
There is also evidence for three-dimensional simi-
larities between hexokinases and other kinds of pro-
tein even though no relationships between the corre-
sponding sequences can be detected by standard
w xmethods. On the one hand, Kabsch et al. 173 recog-
nized that the ATP-binding site of actin had some
features in common with the corresponding region of
yeast hexokinase, and similar observations were made
in comparing actin with the 70-kDa heat shock pro-
w x w xtein Hsc70 174,175 . Bork et al. 176 subsequently
compared the three-dimensional structures of all three
proteins and confirmed that the parts of the molecules
concerned with binding and hydrolysis of ATP were
very similar, especially so for actin and Hsc70, but
with essentially the same domain organization in all
three proteins.
The three-dimensional structures allowed align-
ment of the sequences and detection of motifs that
could not have been found by studying the sequences
alone. The same motifs proved to be present in rat
hexokinase D, several other sugar kinases fucokinase
from E. coli, glycerokinase from E. coli and B.
subtilis, gluconokinase from B. subtilis, xylulokinase
from E. coli and ribulokinase from Salmonella ty-
.phimurium and several proteins involved in the
w xprokaryotic cell cycle 176 . Subsequently two phos-
phatases from E. coli, exopolyphosphate phosphatase
and guanosine pentaphosphate phosphatase, were
w xfound to belong to the same superfamily 177 .
w xBork et al. 176 examined whether the similarity
of the sugar kinases to these other proteins could
have arisen by convergent evolution, but concluded
on the basis of qualitative rather than detailed statis-
.tical arguments that the unusually complicated struc-
ture of the region of similarity was unlikely to have
arisen twice independently and that, therefore, the
various proteins were homologous. In a later article
w x118 , they argued that convergent evolution had
nonetheless occurred within the sugar kinase group.
A major part of their argument was based on a
misconception, however, because the conclusion that
evolution for glucose specificity has arisen three times
is based on the supposition that the mammalian hex-
okinases D are specific for glucose. If this error is
corrected one is left with very sparse data: yeast
glucokinase, the least thoroughly studied of the yeast
hexokinases, provides the only evidence that glucose
specificity has arisen independently in eukaryotes and
prokaryotes, and a single divergent fructokinase that
.of Z. mobilis provides the only evidence that fruc-
tose specificity has arisen independently in two
branches of the prokaryotic phylogeny.
As we discussed in Section 3.3, the variations in
kinetic behaviour exhibited by the different forms of
hexokinase can probably all be accommodated within
a single type of mechanism, in which the reaction
proceeds through a ternary complex that can be
formed by binding of glucose and MgATP in either
order, but with a preferred order of substrate binding
—more marked for some hexokinases than for oth-
w xers. Wilson and Schwab 178 recently reexamined
the mechanism in the light of the recent discovery of
the similarity in structure with actin. They pointed
out that although most discussion of MgATP binding
to the yeast hexokinase molecule had focused on a
region of the structure known as the large lobe, there
was reason to believe that the other region, the small
lobe, was also involved. If MgATP were to bind
before glucose this would probably cause the two
lobes to move closer together, producing a structure
lacking glucose but otherwise similar to the reactive
ternary complex with both substrates bound. As glu-
cose binds to a site deep within the active-site cleft it
would not have easy access to it if the structure were
partially closed already. Hence binding of MgATP
before glucose would not prevent catalysis altogether
but would be less favourable than the alternative
order with glucose binding first.
Three-dimensional structures are not yet available
for any of the mammalian hexokinases, but the se-
quence similarities imply that the crystallographic
studies of the P and P isoenzymes of yeast hexoki-I II
nase constitute a valuable resource for modelling the
mammalian enzymes and predicting which are the
functionally important residues. This needs to be
done cautiously, however, especially in relation to
hexokinase D, because the markedly different kinetic
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behaviour from that of the yeast isoenzymes must be
related to some significant differences in structure.
w xThe recent demonstration 179,180 that two proteins
—one of them admittedly artificial—can share 50%
sequence identity yet have well defined but entirely
different three-dimensional structures underlines the
need for such caution. A detailed study of the general
question of the relationship between sequence align-
ments and three-dimensional structures has appeared
w xrecently 181 .
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